These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16750890)

  • 1. Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients.
    Maxwell CR; Liang Y; Kelly MP; Kanes SJ; Abel T; Siegel SJ
    Neuroscience; 2006 Sep; 141(3):1257-64. PubMed ID: 16750890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.
    Kelly MP; Isiegas C; Cheung YF; Tokarczyk J; Yang X; Esposito MF; Rapoport DA; Fabian SA; Siegel SJ; Wand G; Houslay MD; Kanes SJ; Abel T
    Neuropsychopharmacology; 2007 Mar; 32(3):577-88. PubMed ID: 16738544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
    Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
    Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha.
    Gould TJ; Bizily SP; Tokarczyk J; Kelly MP; Siegel SJ; Kanes SJ; Abel T
    Neuropsychopharmacology; 2004 Mar; 29(3):494-501. PubMed ID: 14694347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential.
    Maxwell CR; Liang Y; Weightman BD; Kanes SJ; Abel T; Gur RE; Turetsky BI; Bilker WB; Lenox RH; Siegel SJ
    Neuropsychopharmacology; 2004 Apr; 29(4):739-46. PubMed ID: 14735128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
    Simosky JK; Stevens KE; Adler LE; Freedman R
    Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
    Ehrlichman RS; Maxwell CR; Majumdar S; Siegel SJ
    J Cogn Neurosci; 2008 Aug; 20(8):1403-14. PubMed ID: 18303985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of restraint and haloperidol on sensory gating in the midbrain of awake rats.
    Anstrom KK; Cromwell HC; Woodward DJ
    Neuroscience; 2007 May; 146(2):515-24. PubMed ID: 17360124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.
    Kelly MP; Stein JM; Vecsey CG; Favilla C; Yang X; Bizily SF; Esposito MF; Wand G; Kanes SJ; Abel T
    Mol Psychiatry; 2009 Apr; 14(4):398-415, 347. PubMed ID: 19030002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
    Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function.
    Bickel S; Lipp HP; Umbricht D
    Neuropsychopharmacology; 2008 Jun; 33(7):1680-9. PubMed ID: 17712349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticofugal feedback for auditory midbrain plasticity elicited by tones and electrical stimulation of basal forebrain in mice.
    Zhang Y; Hakes JJ; Bonfield SP; Yan J
    Eur J Neurosci; 2005 Aug; 22(4):871-9. PubMed ID: 16115210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotine vary across two auditory evoked potentials in the mouse.
    Metzger KL; Maxwell CR; Liang Y; Siegel SJ
    Biol Psychiatry; 2007 Jan; 61(1):23-30. PubMed ID: 16497274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine improves deficient sensory inhibition in DBA/2 mice.
    Simosky JK; Freedman R; Stevens KE
    Brain Res; 2008 Oct; 1233():129-36. PubMed ID: 18687314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronically increased Gsalpha signaling disrupts associative and spatial learning.
    Bourtchouladze R; Patterson SL; Kelly MP; Kreibich A; Kandel ER; Abel T
    Learn Mem; 2006; 13(6):745-52. PubMed ID: 17142304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosterone modulates auditory gating in mouse.
    Maxwell CR; Ehrlichman RS; Liang Y; Gettes DR; Evans DL; Kanes SJ; Abel T; Karp J; Siegel SJ
    Neuropsychopharmacology; 2006 May; 31(5):897-903. PubMed ID: 16123740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.
    Yee BK; Keist R; von Boehmer L; Studer R; Benke D; Hagenbuch N; Dong Y; Malenka RC; Fritschy JM; Bluethmann H; Feldon J; Möhler H; Rudolph U
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17154-9. PubMed ID: 16284244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.